About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Novel Drug Delivery Technique Via Retroject Device

NCT02051946·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Molly Walsh

Age

55–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

age 55 years or older of both sexes
IOP \>20 mmHg on maximal treatment
\<20/200 visual acuity
willing to sign informed consent forms

You may not be if

monocular patients with bleeding disorders
patients on anticoagulant or antiplatelet medications
patients who had prior laser surgeries (SLT or ALT)

The record

StatusCompleted

PhasePhase 1–2

Taking part9

StartedMay 2014

UpdatedFeb 17, 2017

Conditions

Where1

Duke University Eye Center
Durham, North Carolina, United States

Clareo Health | Novel Drug Delivery Technique Via Retroject Device